NCT01187108View on ClinicalTrials.gov

Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
ErythrocytosisMountain Sickness
Interventions
DRUG

N-acetylcysteine

NAC 600 mg oral once daily

DRUG

Acetazolamide

Acetazolamide 250 mg oral once daily

DRUG

Placebo pills

1 (or 2 in the placebo group) empty gel capsules

Trial Locations (1)

Unknown

Chronic mountain sickness clinic, Cerro de Pasco

All Listed Sponsors
collaborator

Universidad Peruana Cayetano Heredia

OTHER

collaborator

Jackson, Brian, M.S.

INDIV

collaborator

Thomas H Maren Foundation

UNKNOWN

lead

University of Colorado, Denver

OTHER

NCT01187108 - Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru | Biotech Hunter | Biotech Hunter